Literature DB >> 12135775

Local carboxyfullerene protects cortical infarction in rat brain.

Anya Maan-Yuh Lin1, Su-Feng Fang, Shin-Zong Lin, Cheng-Kong Chou, Tieng-Yau Luh, Low-Tone Ho.   

Abstract

The neuroprotective effect of carboxyfullerene, a water-soluble derivative of fullerene, on the transient focal ischemia-reperfusion injury was investigated in rat brain. A focal infarction in the cerebral cortex was consistently observed 24 h after a 60-min transient ischemia by occlusion of the right middle cerebral artery and bilateral common carotid arteries. The fluorescent end products of lipid peroxidation were increased in the infarcted cortical area. Furthermore, the GSH level was decreased in the infarcted cortex. Carboxyfullerene was either intravenously (6 mg/kg) or intracerebroventricularly (0.1, 0.3 mg per rat) infused to the chloral hydrate-anesthetized Sprague-Dawley rats 30 min prior to transient ischemia-reperfusion. No protection of cortical infarction was observed after intravenous administration of carboxyfullerene. In contrast, intracerebroventricular infusion of carboxyfullerene not only attenuated cortical infarction but also prevented both the elevated lipid peroxidation and the depleted GSH level induced by transient ischemia-reperfusion. Adverse behavioral changes were simultaneously observed in rats receiving intracerebroventricular infusion of carboxyfullerene (0.3 mg per rat), including writhing accompanied by trunk stretch and even death. Our data suggest that intracerebroventricular infusion of carboxyfullerene may attenuate oxidative injuries by transient ischemia-reperfusion. Nevertheless, undesired side effects may limit the usefulness of carboxyfullerene in biological organisms. Copyright 2002 Elsevier Science Ireland Ltd. and the Japan Neuroscience Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135775     DOI: 10.1016/s0168-0102(02)00056-1

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  19 in total

Review 1.  The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Authors:  Qihai Liu; Quanjun Cui; Xudong Joshua Li; Li Jin
Journal:  Connect Tissue Res       Date:  2014-01-24       Impact factor: 3.417

2.  Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C3] in Mice and Primates.

Authors:  Joshua I Hardt; Joel S Perlmutter; Christopher J Smith; Kevin L Quick; Ling Wei; Subhasish K Chakraborty; Laura L Dugan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-10       Impact factor: 2.441

3.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.

Authors:  Alexandre S Basso; Dan Frenkel; Francisco J Quintana; Frederico A Costa-Pinto; Sanja Petrovic-Stojkovic; Lindsay Puckett; Alon Monsonego; Amnon Bar-Shir; Yoni Engel; Michael Gozin; Howard L Weiner
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells--a potential novel treatment for intervertebral disc degeneration.

Authors:  Qihai Liu; Li Jin; Francis H Shen; Gary Balian; Xudong Joshua Li
Journal:  Spine J       Date:  2013-05-10       Impact factor: 4.166

5.  Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles.

Authors:  Qihai Liu; Li Jin; Brian H Mahon; Mahendra D Chordia; Francis H Shen; Xudong Li
Journal:  Spine (Phila Pa 1976)       Date:  2013-08-01       Impact factor: 3.468

Review 6.  Catalytic antioxidants and neurodegeneration.

Authors:  Tamara R Golden; Manisha Patel
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

7.  Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability.

Authors:  Ying-ying Zha; Bo Yang; Ming-liang Tang; Qiu-chen Guo; Ju-tao Chen; Long-ping Wen; Ming Wang
Journal:  Int J Nanomedicine       Date:  2012-06-29

Review 8.  Nanomedicine in cerebral palsy.

Authors:  Bindu Balakrishnan; Elizabeth Nance; Michael V Johnston; Rangaramanujam Kannan; Sujatha Kannan
Journal:  Int J Nanomedicine       Date:  2013-11-01

Review 9.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007

10.  Effects of Aqueous Dispersions of C60, C70 and Gd@C82 Fullerenes on Genes Involved in Oxidative Stress and Anti-Inflammatory Pathways.

Authors:  Elena V Proskurnina; Ivan V Mikheev; Ekaterina A Savinova; Elizaveta S Ershova; Natalia N Veiko; Larisa V Kameneva; Olga A Dolgikh; Ivan V Rodionov; Mikhail A Proskurnin; Svetlana V Kostyuk
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.